Stock screenerAll disclosures →
EDGAR →
IONS
Conviction 20HealthcareScan · Tue, Sep 8, 2026IONS$56.67-2.45%
ResistanceSupportVol 14Insider sell4
3
Vol MA14 2.75M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price56.67
Change-2.45%
Gap-9.88%
Rel volume3.27×
Avg volume2.53M
Avg $ vol149.88M
SMA 2059.48
SMA 5060.75
SMA 20073.33
Price vs 50-6.72%
Price vs 200-22.73%
MA stackbearish
50/200 cross—
Supertrenddown · 61.87
RSI (14)41
MACD hist-0.22
MACD crossbear · 1d
Stoch %K / %D37 / 23
ADX (14)18
+DI / −DI18 / 39
RSI divergenceBullish
MACD divergenceBullish
ATR %+4.06%
ADR %3.30%
52w high86.50
52w low51.77
From 52w high-34.49%
Above 52w low+9.46%
New 52w highNo
SqueezeOff
Bollinger width15.90%
%B0.20
Donchian pos36.84%
Donchian high64.19
Donchian low52.28
AVWAP (52w high)68.91
vs AVWAP high-17.77%
AVWAP (52w low)56.88
vs AVWAP low-0.37%
OBV trendDown
Chaikin MF (20)0.11
Today vs 20d3.27×
Avg vol (14d)2.75M
Avg vol (20d)2.53M
Avg $ vol (20d)149.88M
Market cap9.42B
RS 3m (vs SPY)-26.43%
RS 6m (vs SPY)-36.09%
RS line new highNo
Trend template0/8
Technical rank17.9
1 week-6.12%
1 month+0.19%
3 months-22.95%
6 months-24.81%
1 year-7.46%
YTD-28.88%
P/E-24.69
P/B21.41
P/S9.98
P/FCF-29.43
EPS-2.38
Div yield—
ROE-86.73%
ROA-12.74%
Debt/Eq4.00
Current7.89
EV/EBITDA—
Gross margin—
Net margin-40.41%
Rev growth33.83%
EPS growth15.97%
Price target85.17
Target upside50.30%
Analyst ratingBuy
Institutional120.37%
Ent. value10.83B
Revenue267.95M
Net income-114.65M
Gross profit—
Free cash flow-320.03M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out165.26M
Employees1.4K
ListedFri, May 17, 1991
Free float157.03M
Float %95.1%
Short interest20.91M
Days to cover9.6d
Short volume29.6%
Squeeze score67 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.70 vs −$1.09
Last surprise+35.8% beat
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank17.9 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance62.98
Support50.64
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Novartis pelacarsen Lp(a) trial fails, raising doubts for Amgen, LillyQz · Tue, Sep 8, 2026
- Novartis Stock Drops as Trial Failures Ripple Across Biotech PartnersYahoo Finance · Tue, Sep 8, 2026
- Ionis Pharmaceuticals Shares Fall After Pelacarsen Phase 3 Trial Misses Primary EndpointAdvfn · Tue, Sep 8, 2026
- Novartis Late-Stage Cardiovascular Outcome Study Fails, Stock DownYahoo Finance · Mon, Sep 7, 2026
- Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study GoalYahoo Finance · Mon, Sep 7, 2026
- Novartis, Ionis drug failure spurs questions about an emerging class of heart medicinesBiopharmadive · Sat, Sep 5, 2026
- NVS, IONS, AMGN Stocks Drop After-Hours — What’s Driving The Selloff?Stocktwits · Fri, Sep 4, 2026
- Novartis, Ionis Tumble On Surprise Flop For Heart DrugYahoo Finance · Fri, Sep 4, 2026
- Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)Yahoo Finance · Fri, Sep 4, 2026
- This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.Yahoo Finance · Fri, Sep 4, 2026
Congress activity
Disclosed STOCK Act trades in IONS
No recent disclosed trades by Congress in IONS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IONS · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BENNETT C FRANK EVP, Chief Scientific Officer · Common Stock · 2026-08-31 | Acquire | 110 | $6K | 2026-08-31 | 2026-09-02 |
Birchler Brian EVP, Corp and Development Ops · Common Stock · 2026-08-31 | Acquire | 58 | $3K | 2026-08-31 | 2026-09-02 |
Monia Brett P Chief Executive Officer · Common Stock · 2026-08-31 | Acquire | 98 | $5K | 2026-08-31 | 2026-09-02 |
O'NEIL PATRICK R. EVP CLO & General Counsel · Common Stock · 2026-08-31 | Acquire | 63 | $3K | 2026-08-31 | 2026-09-02 |
HERMAN JOAN E Director · Restricted Stock Unit · 2026-07-15 | Exercise | 5.22K | — | 2026-07-15 | 2026-07-17 |
HERMAN JOAN E Director · Common Stock · 2026-07-15 | Exercise | 5.22K | — | 2026-07-15 | 2026-07-17 |
BERTHELSEN SPENCER R Director · Common Stock · 2026-07-15 | Exercise | 5.22K | — | 2026-07-15 | 2026-07-17 |
BERTHELSEN SPENCER R Director · Restricted Stock Unit · 2026-07-15 | Exercise | 5.22K | — | 2026-07-15 | 2026-07-17 |
HANTSON LUDWIG Director · Restricted Stock Unit · 2026-07-15 | Grant | 3.4K | — | 2026-07-15 | 2026-07-17 |
Reikes Peter N Director · Restricted Stock Unit · 2026-07-15 | Grant | 3.4K | — | 2026-07-15 | 2026-07-17 |
SEC filings
EDGAR filings in IONS · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.